Return to search results
Sumatriptan
Tosymra is a prescription nasal spray containing sumatriptan, used to treat migraine headaches in adults. Each spray delivers 10 mg of the medication, which works by narrowing blood vessels in the brain and reducing inflammation. It's manufactured by Upsher-Smith Laboratories and Tonix Medicines. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tosymra is a prescription nasal spray containing sumatriptan, used to treat migraine headaches in adults. Each spray delivers 10 mg of the medication, which works by narrowing blood vessels in the brain and reducing inflammation. It's manufactured by Upsher-Smith Laboratories and Tonix Medicines. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Sumatriptan",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Sumatriptan — ANDA 207101 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207101"
}
]
|
| identifier | ANDA207101 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Sumatriptan |
